Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Hypertrophic cardiomyopathy	5/90	3.701866767392747e-08	9.114232599005328e-07	93.91764705882353	-252.125791973172	AGT;CACNA1C;CACNA1D;LMNA;TTN
KEGG_2021_Human	Dilated cardiomyopathy	5/96	5.132456566866222e-08	9.114232599005328e-07	87.65934065934066	-239.19432283496107	AGT;CACNA1C;CACNA1D;LMNA;TTN
KEGG_2021_Human	Circadian entrainment	5/97	5.4085780869589264e-08	9.114232599005328e-07	86.69565217391305	-237.1712976551275	CACNA1C;CACNA1D;CAMK2G;KCNJ3;KCNJ5
KEGG_2021_Human	Aldosterone synthesis and secretion	5/98	5.69639537437833e-08	9.114232599005328e-07	85.75268817204301	-235.1833019556325	AGT;CACNA1C;CACNA1D;CAMK2G;KCNJ5
KEGG_2021_Human	Dopaminergic synapse	5/132	2.5489885570271496e-07	3.2627053529947513e-06	62.52755905511811	-183.25399152437575	CACNA1C;CACNA1D;CAMK2G;KCNJ3;KCNJ5
KEGG_2021_Human	Oxytocin signaling pathway	5/154	5.506914925979601e-07	5.03489364660992e-06	53.147651006711406	-160.36960249388903	CACNA1C;CACNA1D;CAMK2G;KCNJ3;KCNJ5
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	5/150	4.829507301919332e-07	5.03489364660992e-06	54.641379310344824	-164.10087569329903	AGT;CACNA1C;CACNA1D;CAMK2G;SCN5A
KEGG_2021_Human	GnRH secretion	4/64	7.261673977114379e-07	5.8093391816915035e-06	88.97777777777777	-197.79231847075658	CACNA1C;CACNA1D;KCNJ3;KCNJ5
KEGG_2021_Human	Cholinergic synapse	4/113	7.1460852432057485e-06	4.573494555651679e-05	48.678899082568805	-123.22339060338247	CACNA1C;CACNA1D;CAMK2G;KCNJ3
KEGG_2021_Human	Serotonergic synapse	4/113	7.1460852432057485e-06	4.573494555651679e-05	48.678899082568805	-123.22339060338247	CACNA1C;CACNA1D;KCNJ3;KCNJ5
KEGG_2021_Human	Retrograde endocannabinoid signaling	4/148	2.085580460264673e-05	0.00012134286314267188	36.68518518518518	-97.05310244366827	CACNA1C;CACNA1D;KCNJ3;KCNJ5
KEGG_2021_Human	Cushing syndrome	4/155	2.5031430482156457e-05	0.0001335009625715011	34.95364238410596	-93.05983781717019	AGT;CACNA1C;CACNA1D;CAMK2G
KEGG_2021_Human	Cortisol synthesis and secretion	3/65	5.7322256772471596e-05	0.0002822018794952448	55.34101382488479	-100.98537671170521	AGT;CACNA1C;CACNA1D
KEGG_2021_Human	Renin secretion	3/69	6.857856994284154e-05	0.0002926018984227906	51.96103896103896	-96.07609532933417	AGT;CACNA1C;CACNA1D
KEGG_2021_Human	Amphetamine addiction	3/69	6.857856994284154e-05	0.0002926018984227906	51.96103896103896	-96.07609532933417	CACNA1C;CACNA1D;CAMK2G
KEGG_2021_Human	Arrhythmogenic right ventricular cardiomyopathy	3/77	9.524734696085732e-05	0.00035857824738205106	46.2972972972973	-87.57744084010389	CACNA1C;CACNA1D;LMNA
KEGG_2021_Human	cAMP signaling pathway	4/216	9.200354274938475e-05	0.00035857824738205106	24.70440251572327	-68.03817439737095	CACNA1C;CACNA1D;CAMK2G;HCN4
KEGG_2021_Human	Insulin secretion	3/86	0.0001324740846980751	0.0004710189678153781	41.230636833046475	-79.65388581050792	CACNA1C;CACNA1D;CAMK2G
KEGG_2021_Human	GnRH signaling pathway	3/93	0.00016720908178540931	0.0005632305912771682	37.99047619047619	-74.4091590745228	CACNA1C;CACNA1D;CAMK2G
KEGG_2021_Human	Glutamatergic synapse	3/114	0.00030562208449801803	0.0009779906703936577	30.72200772200772	-62.06423147737699	CACNA1C;CACNA1D;KCNJ3
KEGG_2021_Human	Vascular smooth muscle contraction	3/133	0.00048114740245030677	0.0014663539884199825	26.16923076923077	-53.85627487542706	AGT;CACNA1C;CACNA1D
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.004034223569531348	45.59090909090909	-53.767249912981214	CACNA1C;CACNA1D
KEGG_2021_Human	Calcium signaling pathway	3/240	0.002662203143410756	0.007407869616447321	14.160940325497288	-29.862034348996023	CACNA1C;CACNA1D;CAMK2G
KEGG_2021_Human	Long-term potentiation	2/67	0.002921615714870147	0.007790975239653725	30.78076923076923	-39.02900444511024	CACNA1C;CAMK2G
KEGG_2021_Human	Cardiac muscle contraction	2/87	0.004878430830648848	0.012008445121597164	23.479411764705883	-30.876399333663745	CACNA1C;CACNA1D
KEGG_2021_Human	Taste transduction	2/86	0.00476943508022695	0.012008445121597164	23.761904761904763	-31.205674037146366	CACNA1C;HCN4
KEGG_2021_Human	GABAergic synapse	2/89	0.005099890907028776	0.012088630298142285	22.933908045977013	-30.23706529396038	CACNA1C;CACNA1D
KEGG_2021_Human	Morphine addiction	2/91	0.005325959501633964	0.01217362171802049	22.412921348314608	-29.62208544121757	KCNJ3;KCNJ5
KEGG_2021_Human	Growth hormone synthesis, secretion and action	2/119	0.008964014539605185	0.019782652777059716	16.98931623931624	-22.939511285821055	CACNA1C;CACNA1D
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.025073915256995663	14.690740740740742	-19.931093924152265	KCNJ3;KCNJ5
KEGG_2021_Human	cGMP-PKG signaling pathway	2/167	0.01714396328141428	0.035393988710016575	11.974242424242425	-16.21420587418702	CACNA1C;CACNA1D
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.035544332653132525	6.897094430992736	-13.07371705691191	CACNA1C;CACNA1D;CAMK2G
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.0480239196622095	9.784825870646767	-13.073912909097736	AGT;CAMK2G
KEGG_2021_Human	Renin-angiotensin system	1/23	0.028125816737661832	0.05294271385912815	40.63636363636363	-20.601670877696893	AGT
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.061331972657576374	8.26054852320675	-10.803362590978235	CACNA1C;CACNA1D
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.0761094931217018	7.192804428044281	-9.169844698845731	CACNA1C;CACNA1D
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.08472041414219648	6.657534246575342	-8.337786615237395	CACNA1C;CACNA1D
KEGG_2021_Human	Carbohydrate digestion and absorption	1/47	0.05671353920929476	0.09551753972091749	19.3768115942029	-11.24402387762608	CACNA1D
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.12056760681612097	5.2459128065395095	-6.1057863985118	CACNA1C;CACNA1D
KEGG_2021_Human	Glioma	1/75	0.0891077855134448	0.14087176423162565	12.003003003003004	-7.236197160831004	CAMK2G
KEGG_2021_Human	Gastric acid secretion	1/76	0.09024597396088518	0.14087176423162565	11.841481481481482	-7.141387005986298	CAMK2G
KEGG_2021_Human	ErbB signaling pathway	1/85	0.10043221696214563	0.15303956870422192	10.56084656084656	-6.37671991533167	CAMK2G
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.16823175149771882	8.94388327721661	-5.375723879218761	AGT
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.16823175149771882	9.130584192439862	-5.49346810373269	CAMK2G
KEGG_2021_Human	Melanogenesis	1/101	0.11828795027183354	0.16823175149771882	8.853333333333333	-5.318405524022337	CAMK2G
KEGG_2021_Human	Glucagon signaling pathway	1/107	0.1249011740201087	0.16946085438295413	8.345911949685535	-4.994589105830365	CAMK2G
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.16946085438295413	8.2668743509865	-4.943743954376122	AGT
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.16946085438295413	8.189300411522634	-4.893732148578802	CAMK2G
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.17663214572812047	3.5628544423440456	-3.410136075895621	AGT;CAMK2G
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.17663214572812047	7.4858757062146895	-4.435243302362896	CAMK2G
KEGG_2021_Human	Oocyte meiosis	1/129	0.1487694756391342	0.1866911066844037	6.892361111111111	-4.041189892105298	CAMK2G
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.2001187504650882	6.2466509062253746	-3.6047270952512624	LMNA
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.20396646925125886	5.987150415721844	-3.427000500776257	AGT
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.20988842672040992	5.562587904360056	-3.1333425612983894	CAMK2G
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.20988842672040992	5.672401433691756	-3.209640069203435	CACNA1D
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.21408584222323568	5.224867724867725	-2.8972129419331236	CACNA1D
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.21408584222323568	5.321885521885521	-2.9652743858654524	CAMK2G
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.22116081906555432	4.841620626151013	-2.6265948500338347	CAMK2G
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.22116081906555432	4.896958410924891	-2.6658400097237527	CAMK2G
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.2419026509124085	4.283224400871459	-2.2275706216550177	CAMK2G
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.24818828340508844	4.077881619937695	-2.079575623138921	CAMK2G
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.2776251921695192	3.503584229390681	-1.6629804039719844	CAMK2G
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.35606104535364813	2.5254901960784313	-0.9533164047874388	AGT
KEGG_2021_Human	Olfactory transduction	1/440	0.4290230576444395	0.4290230576444395	1.9309035687167806	-0.5371969940112262	CAMK2G
